Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 182, Issue 5, Pages 679-692Publisher
WILEY
DOI: 10.1111/bjh.15452
Keywords
allogeneic haematopoietic stem cell transplantation; poor graft function; macrophage; bone marrow microenvironment; haematopoietic stem cell
Categories
Funding
- National Natural Science Foundation of China [81570127, 81530046, 81570121]
- Clinical Medicine Plus X - Young Scholars Project of Peking University [PKU2018LCXQ002]
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81621001]
- National Key Research and Development Program [2017YFA0104500]
- National Key Research and Development Program, Stem Cell and Translation Research [2016YFA0102000]
- Science and Technology Project of Guangdong Province of China [2016B030230003]
Ask authors/readers for more resources
Poor graft function (PGF) is a severe complication of allogeneic haematopoietic stem cell transplantation (allo-HSCT). Murine studies have demonstrated that effective haematopoiesis depends on the specific bone marrow (BM) microenvironment. Increasing evidence shows that BM macrophages (M?s), which constitute an important component of BM immune microenvironment, are indispensable for the regulation of haematopoietic stem cells (HSCs) in the BM. However, little is known about the number and function of BM M?s or whether they directly interact with HSCs in PGF patients. In the current prospective case-control study, PGF patients showed a significant increase in classically activated inflammatory M?s (M1; 218 +/- 011% vs. 082 +/- 006%, P<00001), a striking reduction in alternatively activated anti-inflammatory M?s (M2; 302 +/- 031% vs. 2189 +/- 090%, P<00001), resulting in a markedly increased M1/M2 ratio (082 +/- 006 vs. 006 +/- 0002; P<00001) in the BM compared with good graft function patients. Meanwhile, standard monocyte subsets were altered in PGF patients. Dysfunctional BM M?s, which were characterized by reduced proliferation, migration and phagocytosis, were evident in PGF patients. Furthermore, BM M?s from PGF patients with high tumour necrosis factor- and interleukin 12 levels and low transforming growth factor- levels, led to impaired BM CD34(+) cell function. In summary, our data indicate that an unbalanced BM M1/M2 ratio and dysfunctional M?s may contribute to the occurrence of PGF following allo-HSCT.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available